Brian G Feagan Selected Research

Sodium Glutamate (Accent)

5/2006	Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
5/2005	Unemployment and disability in patients with moderately to severely active Crohn's disease.
2/2004	Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.
10/2003	The effects of infliximab maintenance therapy on health-related quality of life.
5/2002	Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian G Feagan Research Topics

Disease

154	Crohn Disease (Crohn's Disease) 04/2024 - 01/2002
122	Ulcerative Colitis 04/2024 - 12/2003
63	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2024 - 12/2003
27	Infections 04/2024 - 05/2006
19	Necrosis 08/2023 - 12/2011
18	Inflammation (Inflammations) 05/2024 - 05/2007
17	Hemorrhage 02/2024 - 12/2005
13	Neoplasms (Cancer) 04/2024 - 10/2009
10	Body Weight (Weight, Body) 01/2021 - 02/2004
7	Abdominal Pain (Pain, Abdominal) 10/2022 - 12/2008
7	Fistula 02/2019 - 08/2003
6	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2023 - 08/2013
6	Rheumatoid Arthritis 01/2019 - 05/2002
5	Pathologic Constriction (Stenosis) 10/2023 - 05/2006
5	Pouchitis 03/2023 - 08/2017
5	Headache (Headaches) 02/2023 - 08/2003
4	Fibrosis (Cirrhosis) 05/2024 - 01/2022
4	Ulcer 10/2023 - 01/2012
3	Respiratory Tract Infections (Respiratory Tract Infection) 12/2023 - 07/2018
3	Nasopharyngitis 12/2023 - 08/2013
3	Colitis 11/2023 - 06/2005
3	Herpes Zoster 01/2023 - 01/2017
3	Tuberculosis (Tuberculoses) 01/2023 - 10/2009
3	Multiple Sclerosis 11/2022 - 08/2015
3	Abscess 01/2022 - 01/2018
3	Psoriatic Arthritis 01/2022 - 01/2019
3	Arthritis (Polyarthritis) 02/2021 - 01/2018
3	Fatigue 02/2019 - 12/2008
3	Ankylosing Spondylitis 01/2019 - 01/2018
3	Progressive Multifocal Leukoencephalopathy 01/2019 - 11/2005
2	Knee Osteoarthritis 04/2024 - 09/2008
2	Enterocolitis 01/2022 - 01/2022
2	Erythema Nodosum 02/2021 - 01/2018
2	Eosinophilic Esophagitis 01/2021 - 09/2019
2	Skin Neoplasms (Skin Cancer) 01/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

42	vedolizumabIBA 03/2024 - 06/2005
35	Infliximab (Remicade)FDA Link 01/2022 - 05/2002
34	Monoclonal AntibodiesIBA 08/2023 - 02/2004
27	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 05/2002
23	Tumor Necrosis Factor InhibitorsIBA 08/2023 - 12/2011
19	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021 - 02/2004
17	Ustekinumab (CNTO 1275)FDA Link 02/2024 - 10/2008
16	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022 - 01/2002
15	Interleukin-23 (Interleukin 23)IBA 07/2023 - 10/2008
14	IntegrinsIBA 12/2020 - 06/2005
13	golimumab FDA Link 03/2024 - 01/2014
13	Leukocyte L1 Antigen Complex (Calgranulin)IBA 06/2023 - 11/2008
11	C-Reactive ProteinIBA 10/2022 - 05/2007
10	Immunosuppressive Agents (Immunosuppressants)IBA 12/2023 - 04/2012
10	Phenobarbital (Luminal)FDA Link 10/2023 - 05/2006
10	Interleukin-12 (IL 12)IBA 07/2023 - 10/2008
9	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2008
9	Adalimumab (Humira)FDA Link 09/2023 - 11/2008
8	ozanimodIBA 04/2024 - 01/2016
8	AntibodiesIBA 11/2021 - 08/2004
7	GLPG0634IBA 08/2023 - 01/2021
7	risankizumabIBA 07/2023 - 01/2017
7	tofacitinibIBA 01/2022 - 01/2017
6	guselkumabIBA 03/2024 - 01/2022
6	Janus Kinase InhibitorsIBA 11/2023 - 01/2017
6	Methotrexate (Mexate)FDA LinkGeneric 09/2023 - 06/2004
6	Certolizumab Pegol FDA Link 01/2022 - 07/2007
6	CytokinesIBA 11/2019 - 10/2008
5	Sphingosine-1-Phosphate ReceptorsIBA 11/2023 - 01/2020
5	mirikizumabIBA 11/2023 - 01/2020
5	InterleukinsIBA 02/2023 - 12/2012
5	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 01/2002
5	Sodium Glutamate (Accent)IBA 05/2006 - 05/2002
4	Janus Kinase 1IBA 08/2023 - 01/2020
4	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2023 - 07/2002
4	Serum AlbuminIBA 01/2020 - 04/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2019 - 07/2002
4	Natalizumab (Tysabri)FDA Link 01/2016 - 11/2005
4	Azathioprine (Imuran)FDA LinkGeneric 08/2014 - 09/2004
4	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2014 - 09/2004
3	etrolizumabIBA 01/2022 - 07/2014
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
3	AntimetabolitesIBA 01/2018 - 02/2008
3	LactoferrinIBA 07/2017 - 11/2008
3	Analgesics (Analgesic Drugs)IBA 01/2017 - 05/2006
3	Narcotics (Narcotic Analgesics)IBA 01/2017 - 05/2006
3	Metronidazole (Metric)FDA LinkGeneric 01/2009 - 07/2002
2	Immunologic Factors (Immunomodulators)IBA 04/2024 - 12/2008
2	etrasimodIBA 04/2024 - 01/2023
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2023 - 01/2023
2	KHK4083IBA 10/2020 - 07/2020
2	upadacitinibIBA 01/2020 - 01/2020
2	GED0301IBA 01/2020 - 01/2018
2	AlbuminsIBA 01/2020 - 08/2017
2	Alkaline PhosphataseIBA 01/2020 - 01/2017
2	LipidsIBA 01/2020 - 01/2017
2	secukinumabIBA 01/2019 - 12/2012

Therapy/Procedure

131	Therapeutics 03/2024 - 01/2002
9	Biological Therapy 01/2022 - 11/2016
9	Remission Induction 12/2020 - 01/2002
5	Drug Therapy (Chemotherapy) 01/2022 - 02/2014
4	Colectomy 01/2023 - 10/2009
3	Restorative Proctocolectomy 03/2023 - 01/2018
2	Liver Transplantation 12/2020 - 05/2019
2	Aftercare (After-Treatment) 01/2020 - 10/2009